Akanda (AKAN) Retained Earnings (2020 - 2025)
Akanda (AKAN) posted quarterly Retained Earnings of -$103.1 million for Q4 2025, down 79.42% year-over-year from -$500.9 million in Q4 2024, and down 76.97% quarter-over-quarter from -$58.3 million in Q2 2025.
Akanda (AKAN) Retained Earnings (2020 - 2025) Analysis & Trends
Akanda's Retained Earnings history runs 6 years deep, the most recent figure standing at -$103.1 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 79.42% year-over-year to -$103.1 million; the TTM figure through Dec 2025 stood at -$103.1 million (down 79.42% YoY), while the FY2025 annual figure was -$103.1 million, down 79.42% from the prior year.
- Retained Earnings for Q4 2025 stood at -$103.1 million, down from -$58.3 million in the prior quarter.
- The five-year high for Retained Earnings was -$12.0 million in Q2 2022, with the low at -$103.1 million in Q4 2025.
- The 5-year median for Retained Earnings is -$53.4 million (2023), against an average of -$44.6 million.
- The sharpest annual moves came in 2021 and 2025: Retained Earnings slumped 157.5% in 2021, then decreased 3.94% in 2025.
- Akanda's Retained Earnings stood at -$13.3 million in 2021, then plunged by 58.63% to -$21.1 million in 2022, then plunged by 153.05% to -$53.4 million in 2023, then retreated by 7.68% to -$57.5 million in 2024, then sank by 79.42% to -$103.1 million in 2025.
- Business Quant data shows AKAN's Retained Earnings at -$103.1 million in Q4 2025, -$58.3 million in Q2 2025, and -$57.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Akanda | 266,801.66 | 266,801.66 | - | -103.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -103.09 Mn |
| Jun 30, 2025 | -58.25 Mn |
| Dec 31, 2024 | -57.46 Mn |
| Jun 30, 2024 | -56.05 Mn |
| Dec 31, 2023 | -53.36 Mn |
| Jun 30, 2023 | -26.97 Mn |
| Dec 31, 2022 | -21.09 Mn |
| Jun 30, 2022 | -12.02 Mn |
| Dec 31, 2021 | -13.29 Mn |
| Dec 31, 2020 | -5.16 Mn |